CLINICAL_TRIALS
trial_result
· 2022-08-31
Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial evaluating FMX114 vs vehicle in adults with atopic dermatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vyne Therapeutics Inc. | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED